Skip to content

Septerna, Inc. SEPN Discovery Research Milestones — Variable Consideration

Similar metrics at other companies

MoonLake Immunotherapeutics logo
MLTXLicense — Variable consideration amount
$8.1M0.0%
Zymeworks logo
ZYMEResearch Milestone — Research and development collaborations (note 11)
$8.75M
Zymeworks logo
ZYMEResearch, Development and Commercial Milestones — Research and development collaborations (note 11)
$0
MoonLake Immunotherapeutics logo
MLTXLicense — Revenue remaining performance obligation additional variable consideration amount
$344.3M+6.2%
Nuvation Bio logo
NUVBResearch And Development Service Revenue — Milestone Received
$3.8M
Dianthus Therapeutics logo
DNTHMilestone — Revenue Recognition Milestone Method Pending
$15M0.0%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept sepn:VariableConsideration.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s discovery research milestones — variable consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s discovery research milestones — variable consideration?
Septerna, Inc. (SEPN) reported discovery research milestones — variable consideration of $2M in Q1 2026.
What does discovery research milestones — variable consideration mean?
This metric quantifies the variable consideration associated with discovery research milestones that is constrained or subject to the achievement of future scientific outcomes. It captures the portion of contract revenue that is contingent upon the successful completion of research phases or the attainment of specific development targets. Monitoring this metric helps investors assess the company's exposure to performance-based revenue streams and the likelihood of realizing future milestone payments.